Variations in the use of definitive chemoradiotherapy and immunoradiotherapy for patients with locally advanced head and neck cancer.

e18074Background: Clinical practice guidelines recommend definitive concurrent bi-modality treatment, either with chemoradiotherapy (CRT) or immunoradiotherapy (IRT) using cetuximab, for locally ad...